Tuberculosis (TB), which has afflicted humanity for thousands of years, is a worldwide pandemic disease caused mainly by Mycobacterium tuberculosis. The first-line treatment for an active TB infection is the antibiotic isoniazid (INH). Different derivatives of isoniazid are prepared by changing the chemical structure and introducing different moieties. In this review, the aim is to encapsulate different methods for the synthesis of isoniazid derivatives and their pharmacological activities. Through this exploration, insights into the potential avenues for the development of more effective treatments against TB are offered.
Isoniazid, Mycobacterium Tuberculosis, Mycolic Acid, Pulmonary TB, Haemoptysis, Antimycobacterial, Anticancer.
Adithya, G., Kumar, A. S., and John, L. A. (2024). A Review Based on the Synthesis of Isoniazid Derivatives and their Pharmacological Activities. Dale View's Journal of Clinical Pharmacology and Pharmacotherapeutics, 1(1), 8-14.